Pomegranate Supplementation and Well-Being Among Medical Students and Residents
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Antioxidant
- Burnout, Professional
- Psychological Distress
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Phase 1 is a single group feasibility pilot in 10 participants, all of whom will receive the nutritional supplement. Phase 2 is a parallel double blinded trial in 40 participants, half of whom will receive the supplement and half of whom will receive a placebo.Masking: Double (Participant, Investigator)Masking Description: Phase 1 is not masked, but in phase 2 the participants and investigator will be masked (double blind).Primary Purpose: Other
Participation Requirements
- Age
- Between 21 years and 40 years
- Gender
- Both males and females
Description
This is a pilot study to investigate the feasibility of conducting a randomized trial of pomegranate supplementation in medical students and residents, and to see whether there is evidence of an effect on reported emotional and physical well-being. Phase 1 will be a pilot with 10 participants in whi...
This is a pilot study to investigate the feasibility of conducting a randomized trial of pomegranate supplementation in medical students and residents, and to see whether there is evidence of an effect on reported emotional and physical well-being. Phase 1 will be a pilot with 10 participants in which all will receive the pomegranate supplement for 28 days. In phase 2, we will randomize 40 participants (1:1) to receive either the pomegranate supplement or a placebo. For both phases, we will measure self reported emotional and physical well-being using several questionnaires, and we will conduct laboratory testing for measures of oxidative stress and inflammatory biomarkers in blood, and for a metabolite of pomegranate in urine.
Tracking Information
- NCT #
- NCT03063372
- Collaborators
- University of Rhode Island
- Investigators
- Principal Investigator: Joshua Mann, MD, MPH University of Mississippi Medical Center
Get Well Soon